Back to Journals » Therapeutics and Clinical Risk Management » Volume 14
Original Research
Levodopa/carbidopa/entacapone versus levodopa/dopa-decarboxyiase inhibitor for the treatment of Parkinson's disease: systematic review, meta-analysis, and economic evaluation
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
18,179 | Dovepress* | 15,398+ | 1,660 | 17,058 | |
PubMed Central* | 2,781 | 769 | 3,550 | ||
Totals | 18,179 | 2,429 | 20,608 | ||
*Since 16 April 2018 |
View citations on PubMed Central and Google Scholar